The Senate Agriculture Committee will take up the farm bill next week, and a number of amendments targeting the meat industry are expected to be offered. Two of the most potentially damaging are the Schumer amendment, based on his bill, the Family Grocery and Farmer Relief Act, and mandatory country of origin labeling. First, the Schumer bill makes it unlawful for a major meat packer to control more than one major type of meat, forcing the biggest players to choose a single line of business instead of producing beef, pork, and poultry. It directs the Federal Trade Commission (FTC) to design and enforce divestiture plans, delivering structural change across the industry. Beef margins are deeply in the red while broiler margins are near five-...
Weighing in on strategic realignment
WPI’s team was retained by the governing board of a U.S. industry organization to review a decision, reached by vote, to invest significant assets into the development and management of an export trading company. WPI’s team conducted a formal review of this decision and concluded that the current level of market saturation would limit the benefits of the investment. Based on WPI’s analysis and recommended actions, the board subsequently reversed its decision and undertook a strategic planning effort to identify more impactful investments. On behalf of numerous clients, WPI has not only assisted in identifying strategic paths but also advised their implementation.
What You Need to Know Today: The U.S. and Iran resumed missile strikes after a brief pause in fighting, raising concerns that the five-month conflict could expand across the Middle East. Jordan intercepted Iranian missiles, Kuwait reported a fatal strike, and drone attacks damaged two natural...
Oliver Goldsmith's The Deserted Village, published in 1770, is of a timeless quality. It is a 425-line lament for a disappearing rural world, where prosperous villages give way to larger estates, fewer farmers, and emigration. One passage even follows those leaving for the new colony of Georgia...
The industry has spent two years bracing for GLP-1 medications to hollow out demand, but the data so far tells a more interesting story. Roughly one in eight adults currently uses a GLP-1, and an additional 29 percent of non-users say they would consider it if it became more accessible and cost...